Botanical species · safety record

Atractylodes lancea

The EFSA Compendium of Botanicals holds 6 constituent measurements for Atractylodes lancea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Atractylodes lancea (Thunb.) DC.

6Constituent measurements

0Safety records

5Cited sources

497Licensed products (Canada)

Also recorded as

Atractylodes chinensis (Bunge) Koidz.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 497 licensed products naming Atractylodes lancea as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

Atractylodes lancea, rhizome
Dried rhizome
Rhizoma
Rhizome
Rhizome (Stir-baked with bran)
Rhizome (dry-fried)
Rhizome (prepared)
Rhizome (processed)

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Furan derivatives	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Polyacetylene derivatives	Roots and other underground parts	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Sesquiterpene lactones	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Atractyloside	Roots and other underground parts	Solvent extraction	—	GC-MS	No resolvable identifier
Atractyloside	Roots and other underground parts	Solvent extraction	8980 Microgram/gram	GC-MS	No resolvable identifier
Naphthalene derivatives	—	Essential oil	—	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Lehner, MS., Steigel, A., Bauer, R. Diacetoxy-substituted polyacetylenes from Atractylodes lancea. PHYTOCHEMISTRY, 1997, vol. 46, no. 6, p. 1023-1028. DOI
Duan, Jin-ao., Wang, Liuying., Qian, Shihui., Su, Shulan., Tang, Yuping. A new cytotoxic prenylated dihydrobenzofuran derivative and other chemical constituents from the rhizomes of Atractylodes lancea DC . Archives of pharmacal research, 2008, vol. 31, no. 8, p. 965-969. DOI
Wang, Jin-mei., Kang, Wen-yi. Study on volatile oil of atractylodes chinensis and its inhibitory effect on alpha-glucosidase.. Tianran chanwu yanjiu yu kaifa, 2012, vol. 24, no. 6, p. 790-792.
Chu, Chien-Hua., Chiu, Chi-Ming., Hu, Anren., Wu, Hui-Chung., Ye, Shu-Ping., Ho, Kuo-Chieh., Chen, Liang-Yu. Toxicity attenuation of atractyloside in traditional chinese medicinal herbs after hydrothermal processing . Botanical studies, 2012, vol. 53, no. 4, p. 459-465.
Chen, Liang-Yu., Hu, Anren., Chang, Chih-Jui. The degradation mechanism of toxic atractyloside in herbal medicines by decoction.. Molecules, 2013, vol. 18, p. 2018-2028.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature